Reuters logo
BRIEF-Cardiome Q3 loss per share $0.20
November 14, 2017 / 9:05 PM / in 7 days

BRIEF-Cardiome Q3 loss per share $0.20

Nov 14 (Reuters) - Cardiome Pharma Corp

* Cardiome reports third quarter 2017 financial results

* Sees fy 2017 revenue $24 million to $26 million

* Q3 revenue $6.0 million versus I/B/E/S view $7.3 million

* Q3 loss per share $0.20

* Q3 earnings per share view $-0.18 -- Thomson Reuters I/B/E/S

* Cardiome Pharma Corp - expects existing cash and cash equivalents will be sufficient to fund its operations for at least next 12 months. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below